Related Experiment Videos
Vascular dementia: the Latin American perspective
R L Arizaga1, C A Mangone, R F Allegri
1Memory Disorders Research Center and Neuroepidemiology Branch, National Institute of Social Services for Retirees, Buenos Aires, Argentina.
Alzheimer Disease and Associated Disorders
|December 28, 1999
Summary
Latin America faces accelerated population aging and unique age-related diseases. This review summarizes dementia epidemiology, diagnostic tools, and drug availability in the region.
Area of Science:
- Gerontology and Public Health
- Epidemiology of Aging Populations
Background:
- Population aging is rapidly advancing globally, with Latin America experiencing accelerated demographic shifts.
- Developing regions like Latin America confront population "graying" amidst emerging economies, presenting distinct epidemiological profiles for age-related diseases compared to developed nations.
- The substantial burden of dementia impacts patients, families, healthcare systems, and public health initiatives.
Purpose of the Study:
- To consolidate available epidemiological data on dementia in Latin America.
- To review diagnostic criteria and common assessment tools, including validated and harmonized instruments.
- To examine the drug approval process and availability for dementia and cognitive decline in Argentina.
Main Methods:
- Systematic review of existing dementia epidemiological studies in Latin America.
- Analysis of diagnostic criteria and neuropsychological assessment instruments utilized across the region.
- Inclusion of information on drug regulatory processes and market availability.
Main Results:
- Limited epidemiological data exists for dementia in Latin America.
- Varied diagnostic criteria and assessment tools are employed, with some efforts towards harmonization.
- Information on dementia-related drug approval and availability in Argentina is presented.
Conclusions:
- There is a critical need for more robust dementia epidemiological research in Latin America.
- Standardization of diagnostic and assessment tools is crucial for comparable data and effective interventions.
- Understanding drug access is vital for managing the growing dementia burden in the region.